[ad_1]
JB Chemicals & Pharmaceuticals has received ANDA approval from USFDA for Venlafaxine Extended Release Tablets 37.5mg, 75mg, 150mg and 225mg. This product is based on OROS (Osmotic Controlled Release Oral Delivery System) technology, an advanced and precisely controlled release mechanism.
The product generic approval is bioequivalent and therapeutically equivalent to Osmotica Pharmaceutical US LLC’s 37.5 mg, 75 mg, 150 mg and 225 mg venlafaxine hydrochloride extended-release drug (RLD).
According to IQVIA Health MAT October 2022 data, Venlafaxine Extended-Release Tablets generated approximately $48 million in the US.
Powered by Capital Market – Live
(This story was not edited by Business Standard staff and was generated automatically from a syndicated feed.)
Subscribe to Business Standard Premium
Exclusive stories, curated newsletters, 26 years of archives, e-paper and more!
[ad_2]
Source link